Nov 29, 2019 5:00pm EST

Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter of Fiscal 2020

Nov 25, 2019 9:22am EST

Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2020 Conference Call

Nov 19, 2019 8:30am EST

Medexus Granted Priority Review Status for Gliolan® by Health Canada

Oct 22, 2019 9:00am EDT

Medexus Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Oct 15, 2019 11:43am EDT

Medexus Announces Changes to Senior Management

Sep 19, 2019 8:30am EDT

Medexus Reports Annual Meeting Results

Sep 12, 2019 8:30am EDT

Medexus Reports Health Quality Ontario Recommends Gliolan® for Public Reimbursement

Aug 22, 2019 4:01pm EDT

Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

Aug 16, 2019 11:00am EDT

Medexus Pharmaceuticals Schedules First Quarter Fiscal 2020 Conference Call

Aug 15, 2019 4:05pm EDT

Medexus Announces DTC Eligibility of its Common Shares in the United States